Cardinal Health Q1 2026 Results: Net Income $554M, Up 23.1% YoY
This document is an exhibit from Cardinal Health's 10-Q filing outlining forward-looking risk factors, including competitive pricing pressures, generic pharmaceutical demand, and potential impacts from international tariffs. It also highlights risks related to opioid litigation settlements, regulatory compliance, and supply chain disruptions for medical products.
- Key figure
- Net income $554M · +23.1% YoY